Rimedion Inc.

Part of Ossium Health, Inc.

UEI
CD88LM1CK1A6
CAGE
593N4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Website
rimedion.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Packaging cell lines for lentiviral vector products R41RR032111 National Institutes of Health $198,889
Lentiviral vectors for the treatment of fanconi anemia R41HL099150 National Institutes of Health $223,172
Lentiviral vector for the treatment of fanconi anemia R42HL099150 National Heart Lung and Blood Institute (NIH) $716,476

Quick answers

Is Rimedion Inc. registered in SAM.gov?

Rimedion Inc.'s SAM.gov registration expired on September 26, 2024.

What is Rimedion Inc.'s CAGE code?

Rimedion Inc.'s CAGE code is 593N4, and its Unique Entity ID (UEI) is CD88LM1CK1A6.

What is Rimedion Inc.'s most recent federal award?

Rimedion Inc.'s most recent federal grant award is Packaging cell lines for lentiviral vector products (R41RR032111), from National Institutes of Health, on September 10, 2010.

On GovTribe

See Rimedion Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe